baber/WOPTO huggingface dataset:
Patent AU-4555797-A (AU)
Title: Process for the preparation of substituted aromatic amino compounds
Inventor: BAUMEISTER PETER
IPC: C07C221/00
Filed: 1997-09-19
Abstract: The present invention relates to a hydrogenation process for the preparation of aromatic amino compounds containing directly on the aryl ring or in a side chain one or more entities that may also undergo hydrogenation, such as carbon multiple bonds, nitrile groups, imino groups or carbonyl groups. The preparation is carried out by catalytic hydrogenation of the corresponding aromatic nitro compounds in the presence of a phosphorus-modified noble metal catalyst. The invention relates also to the use of modified noble metal catalysts for the hydrogenation of aromatic nitro compounds containing carbon multiple bonds and/or substituted by nitrile, imino or carbonyl groups.
Patent AU-5180199-A (AU)
Title: Bioadhesive compositions and biomedical electrodes containing them
Inventor: MUNRO HUGH SEMPLE
IPC: A61F13/00
Filed: 1999-07-30
Abstract: Bioadhesive Compositions which comprise a hydrophobic polymer wherein the concentration of the polymer at the surface of the adhesive is greater than its concentration in the bulk of the adhesive are described; and biomedical electrodes, fixation products and wound dressings containing them.
Patent AU-5494590-A (AU)
Title: An improved process for the preparation of 3,5,6- trichloropyridin-2-ol
Inventor: PEWS GARTH
IPC: C07C253/30
Filed: 1990-05-11
Abstract: A process for the preparation of 3,5,6-trichloropyridin-2-ol from trichloroacetyl chloride and acrylonitrile is improved by separately conducting the individual addition, cyclization and aromatization steps. By separating these steps, water and HCl, which are by-products of the latter steps, can be precluded from interfering with the earlier steps. The individual process steps have also been improved.
Patent AU-5583501-A (AU)
Title: Cleat-forming woven fabric article for the manufacture of anti-creep floor mats
Inventor: BURKE WILLIAM O III
IPC: B32B5/18
Filed: 2001-04-09
Abstract: The present invention relates to specific methods of producing cleated rubber-backed floor mats (such as dust control or rubber mats) through the utilization of the combination of a perforated coated woven fabric article (14) and a cushioned platen liner between the article and the metal platen of an in-line dust control mat manufacturing machine. Such a procedure permits a more efficient manner of producing cleated anti-creep dust control mats than previously followed. In particular, the fabric article is in the form of a conveyor belt (16) and is preferably constructed from Teflon (R) -coated woven fiberglass which will not adhere to the tacky rubber component of the target mat and can withstand the extremely high vulcanization temperatures and pressures required during the production of a dust control mat. Further, a method for utilizing the conveyor belt to produce foam rubber cleated anti-creep mats is disclosed. The cleats (24) of these mats have a thicker skin than the rest of the mat, thereby imparting enough strength and structural integrity so that the foam rubber mats may withstand the daily rigors of use, combined with periodic launderings. The produced mat as well as the woven fabric article/cushioned platen liner combination are also encompassed within this invention.
Patent AU-5628796-A (AU)
Title: Coccidiosis poultry vaccine
Inventor: KOK JACOBUS JOHANNES
IPC: A61K39/012
Filed: 1996-07-02
Abstract: This invention relates to novel Eimeria proteins with immunogenic properties, and having lactate dehydrogendse activity as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used for the preparation of a vector vaccine against coccidiosis.
Patent AU-5763996-A (AU)
Title: Hand-held hair dryer
Inventor: IMHOF GERALD
IPC: A45D20/12
Filed: 1996-05-09
Abstract: The invention is directed to a hand-held hair dryer including a housing (10) which is comprised of a handle (12) and an air-moving outer tube (14); the outer tube (14) possesses an inlet port (16) and an outlet port (18) for an air stream, and the housing accommodates a heater and a fan generating and heating the air stream. Arranged in the outer tube (14) is an inner tube (42) receiving at least the heater. In this arrangement, the inner tube (42) is manufactured from a material having a higher thermal stability than the outer tube, and the inner tube (42) terminates flush with at least the outlet port of the outer tube (14) or projects beyond the outlet port of the outer tube (14) in the direction of flow (64). A hair styling implement as, for example, a nozzle (44), a diffuser or the like, is attachable to the inner tube (42).
Patent AU-5890600-A (AU)
Title: Improved metal-based powder compositions containing silicon carbide as an alloying powder
Inventor: NARASIMHAN KALATHUR
IPC: C22C33/02
Filed: 2000-06-23
Abstract: Metallurgical powder compositions are provided that include silicon carbide to enhance the strength, ductility, and machine-ability of the compacted and sintered parts made therefrom. The compositions generally contain a metal powder, such as an iron-based powder, that constitutes the major portion of the composition. A silicon carbide-containing powder is blended with the metal powder, preferably in the form of a silicon carbide powder. Optionally, common alloying powders, lubricants, binding agents, and other powder metallurgy additives can be blended into the metallurgical composition. The metallurgical powder composition is used by compacting it in a die cavity to produce a "green" compact that is then sintered, preferably at relatively high temperatures.
Patent AU-6009098-A (AU)
Title: Disposable inhaler
Inventor: WIDERSTROM CARIN
IPC: A61M11/00
Filed: 1998-01-29
Abstract: A disposable inhaler for administering medicament by inhalation having an inhalation channel through which a user may inhale, a container for containing a dose of medicament, at least one subsidiary container for containing a subsidiary dose of medicament and respective release means for selectively opening one or both of said container and said subsidiary container such that one or both of said dose and said subsidiary dose may be released into said inhalation channel at the same time so as to provide a variable dose and methods of providing a variable quantity of substance in a channel comprising opening a first container containing the substance and selectively opening a second container containing the substance.
Patent AU-6009800-A (AU)
Title: Improved keratinocyte culture and uses thereof
Inventor: HUNZIKER THOMAS
IPC: A61K35/36
Filed: 2000-07-20
Abstract: The present invention relates to the treatment of skin defects by organotypically-cultured autologous keratinocytes isolated from the outer root sheath of anagen or growing hair. Methods for primary, as well as subsequent organotypic cultures (i.e., epidermal equivalents) in fully-defined media supplemented by autologous human serum and substances isolated form blood components, with minimal allogeneic biological supplements, are disclosed herein. Techniques to prepare epidermal equivalents for transplantation by use of a biocompatible glue are also disclosed herein.
Patent AU-6158101-A (AU)
Title: Delivery devices for treatment of vascular disease
Inventor: FALOTICO ROBERT
IPC: A61M37/00
Filed: 2001-05-14
Abstract: The current invention comprises an approach to solving the clinical problem of restenosis, which involves the administration of combinations of drugs to patients undergoing PTCA or stent implantation. In one embodiment of the invention, an antiproliferative agent such as rapamycin, vincristine or taxol is administered in combination with the anti-inflammatory agent, dexamethasone, to patients systemically, either subcutaneously or intravenously. In another embodiment of the invention, the antiproliferative and anti-inflammatory agents are bound in a single formulation to the surface of a stent by means of incorporation within either a biodegradeable or biostable polymeric coating. Alternatively, such drug combinations could be incorporated into a stent constructed with a grooved reservoir.
Patent AU-6158498-A (AU)
Title: Vectors having enhanced expression, and methods of making and uses thereof
Inventor: TARTAGLIA JAMES
IPC: A61P37/04
Filed: 1998-02-13
Abstract: Disclosed and claimed are vectors having enhanced expression and methods for making and using them. Enhancement of expression is from substantially cotemporal expression of at least one first nucleic acid molecule and at least one second nucleic acid molecule. The second nucleic acid molecule encodes a transcription factor or a translation factor or a transcription factor and a translation factor. The contemporaneous expression can be from operably linking the first and second nucleic molecules to a single promoter, or from operably linking the first nucleic acid molecule to a first promoter and the second nucleic molecule to a second promoter wherein the first and second promoters function substantially contemporaneously. Thus, the first and second nucleic molecules can be at the same locus in the vector, or at different loci. The second nucleic acid can encode: one transcription factor or more than one transcription factor; or one translation factor or more than one translation factor; or at least one transcription factor and at least one translation factor. The transcription factor can be from vaccinia H4L, D6, A7, G8R, A1L, A2L, H5R, or combinations thereof. The translation factor can be from a K3L open reading frame, an E3L open reading frame, a VAI RNA, an EBER RNA, a sigma 3 open reading frame, a TRBP open reading frame, or combinations thereof. The vector can be a poxvirus such as an attenuated poxvirus, e.g., NYVAC, or ALVAC.
Patent AU-6166790-A (AU)
Title: Cellular structures for sustaining walls
Inventor: CURT VALERIAN
IPC: E02D29/02
Filed: 1990-08-17
Abstract: PCT No. PCT/CA90/00262 Sec. 371 Date Apr. 21, 1992 Sec. 102(e) Date Apr. 21, 1992 PCT Filed Aug. 17, 1990 PCT Pub. No. WO91/02851 PCT Pub. Date Mar. 7, 1991.A cellular structure for sustaining an embankment is comprised of a vertical facing structure including generally a lattice (1) connected to an embedding structure (2, 3). The embedding structure (2, 3) is extended from the facing structure (1) into the embankment. In a first embodiment, the embedding structure is configured like two lattice sections (2) vertically mounted at the vertical edges of the facing structure (1) and prolonged generally in parallel to the embankment. The embedding structure may also be comprised of at least one U-shaped stirrup (3) connected at each of its free ends to a respective vertical edge of the facing structure (1). In this case, the stirrup (3) is generally extended horizontally in the embankment. The masonry of the facing structure (1) may be carried out in different ways in order to achieve various finishings. The cellular structure may also include a sunk framework (5) between the embankment and the facing structure (1). The cellular structure may thus be filled with stones of smaller or larger dimensions as well as with earth. The use of a geotextile allows the vegetation to grow through the facing structure (1).
Patent AU-6200599-A (AU)
Title: Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of acomposition for the treatment of ischemic stroke
Inventor: NOBUO NAGIA
IPC: A61P9/08
Filed: 1999-09-24
Abstract: The present invention relates to a new means for the treatment of focal ischemic cerebral infarction (ischemic stroke). It has been found that reduction of alpha<SUB>2</SUB>-antiplasmin leads to a significantly smaller focal cerebral infarct size. The invention therefore provides the use of compounds that reduce alpha<SUB>2</SUB>-antiplasmin concentration or activity in vivo, for the preparation of a therapeutical composition for the treatment of focal cerebral ischemic infarction (ischemic stroke).
Patent AU-6246194-A (AU)
Title: Apparatus and method for uniformly irradiating a strand
Inventor: MARLIN NILES SCHUETZ
IPC: B29C59/16
Filed: 1994-02-25
Abstract: An apparatus and method for uniformly irradiating a strand of plastic material by twisting the strand as it is advanced in a plurality of paths transverse to an electron beam. A set of pinch rolls are positioned on opposites ends of the electron beam generator to advance and twist the strand. Lift cams periodically release the twist on the strand at positions of maximum twist by forcing the pinch rolls apart. Each set of pinch rolls includes upper and lower rolls adjacent a medial roll which, in turn, is driven in alternating axial directions to impart twist to the strand. The medial rolls are driven in alternating axial directions by a cammed surface thereon and a cam follower and synchronized to move 180 DEG  out of phase from each other. A series of three spaced apart idler rolls are also provided to form a tandem figure-eight pattern in side view for the strand to compensate for reel set in the strand.
Patent AU-6281500-A (AU)
Title: Method and device for detecting a bending angle on a workpiece
Inventor: WEIGOLD SIMON
IPC: B21D5/02
Filed: 2000-08-10
Abstract: The invention relates to a method and a device for detecting or determining a position or angle modification or a bending angle on a workpiece (2) and a workpiece section (3) during a bending process. To this end, at least one measurement or light beam, in particular, in the form of a light fan (14), originating from a light or measurement beam source (6) is directed onto the workpiece (2), in order to create a corresponding pattern of light, in particular, a line of light (7). The latter can be recorded and detected using a receiver, preferably a camera (8), in such a way that a modification to the angle of the workpiece (2) or its workpiece section (3) can be calculated, based on a position modification of the light pattern. The light or measurement beam source (6) is positioned in such a way, that the line of light (7) or several light lines (7) of this type, which can also be geometrical lines of symmetry or diameter lines, run parallel or substantially parallel to the bending line (11), so that a modification to the position of the bent workpiece section (3) leads to a parallel displacement of this projected line (7).
Patent AU-6436194-A (AU)
Title: Method for precipitating natural avermectins
Inventor: ALI ABDULLAH R
IPC: C12N1/20
Filed: 1994-04-26
Abstract: PCT No. PCT/IB94/00080 Sec. 371 Date Jan. 16, 1996 Sec. 102(e) Date Jan. 16, 1996 PCT Filed Apr. 26, 1994 PCT Pub. No. WO95/03419 PCT Pub. Date Feb. 2, 1995A process for separating a natural B avermectin from a natural avermectin containing fermentation broth by using an aqueous precipitation. The process comprises extracting natural avermectins from the fermentation broth with a water miscible solvent and adding sufficient water to precipitate the natural B avermectins. Preferably, the water miscible solvent is a C1-C3 alcohol, acetone, or acetonitrile. In addition, an acid, base, salt or surfactant may be added to facilitate the precipitation. This invention provides an isolation technique that substitutes the use of an aqueous precipitation for nonaqueous solvent precipitations. The reduction in use of nonaqueous solvents provides economic, environmental and safety benefits.
Patent AU-6503100-A (AU)
Title: Driving circuits for switch mode rf power amplifiers
Inventor: SANDER WENDELL
IPC: H03G3/00
Filed: 2000-07-31
Abstract: The present invention, generally speaking, provides an RF amplifier circuit architecture that enables high efficiency to be achieved while avoiding complicated matching networks and load networks. The active device may be of the bipolar transistor type or the FET (field effect transistor) type. A simple driving circuit is provided for each type of active device. In accordance with one embodiment of the invention, a single-ended switch mode RF amplifier includes an RF input signal; an active device having a control terminal; and a non-resonant driving circuit for receiving the RF input signal and controlling a signal applied to the control terminal so as to operate the active device in switch mode.
Patent AU-6772887-A (AU)
Title: Process for producing 4-androstene-3,17-dion and 1,4- androstadiene-3,17-dion
Inventor: WEBER ALFRED
IPC: C12P33/00
Filed: 1986-12-09
Abstract: Process for manufacturing 4-androstene-3,17 dion and 1,4 androstadiene-3,17-dion of the general formula (I) where ..... is a simple bond or a double bond, characterized by the fact that  alpha -sitosterine of formula (II) is fermented with a culture of a strain of micro-organisms suitable for breaking down the lateral sterine chain.
Patent AU-6776500-A (AU)
Title: Method and computer program product for assessing neurological conditions and treatments using evoked response potentials
Inventor: GRANGER RICHARD
IPC: G06F19/00
Filed: 2000-08-10
Abstract: A method is provided for diagnosing the presence of a neurological disorder or otherwise assessing the neurological condition of a patient. The method also allows the assessment of a treatment regimen used by a patient. The method includes the collection and analysis of ERP data. The method of the invention begins by conducting a plurality of ERP trials on a patient. The data from the ERP trials in then characterized to produce a single characterizing ERP signal vector for the patient. Projections based on the characterizing EPR signal vector are then generated. The projections are compared to information derived from the ERP data of patients having known neurological conditions. To perform diagnosis, the projections are compared to standards, such as one or more characterizing ERP signal vectors from known healthy patients, and one or more characterizing ERP signal vectors from patients known to have a disorder. The probable presence or absence of the neurological disorder is decided by a weighted vote of the projections, where the weighting is a function of how closely each projection compares to the respective standards. Projections can also be used to perform other types of neurological assessment, such as tracking a patient's response to a treatment regimen, assessing the treatability of a patient with respect to a particular regimen, or determining the effects of a particular regimen.
Patent AU-6805994-A (AU)
Title: O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
Inventor: MCMURRY THOMAS BRIAN
IPC: A61K31/52
Filed: 1994-06-08
Abstract: O &cir& _<6>-hetarylalkyl- or naphthylalkylguanine derivatives of formula (I) wherein Y is H, ribosyl, deoxyribosyl, or R"XCHR"', wherein X is O or S, R'' and R''' are alkyl, or substituted derivatives thereof; R' is H, or alkyl or hydroxyalkyl; R is (i) a cyclic group having at least one 5- or 6-membered heterocyclic ring, optionally with a carbocyclic or heterocyclic ring fused thereto, the or each heterocyclic ring having at least one hereto atom chosen from O, N or S, or a substituted derivative thereof; or (ii) naphthyl or a substituted derivative thereof; and pharmaceutically acceptable salts thereof, exhibit the ability to deplete O &cir& _<6>-alkylguanine-DNA alkyltransferase (ATase) activity. A process for preparation of the compounds is described. The compounds have utility in combination with alkylating agents in the chemotherapeutic treatment of tumour cells.
Patent AU-6862394-A (AU)
Title: Electrosurgical stapling device
Inventor: YATES DAVID C
IPC: A61B18/04
Filed: 1994-07-20
Abstract: An surgical stapling instrument is provided which uses a thermogenic energy preferably bipolar radiofrequency energy for cauterization and/or welding tissue. The instrument compresses tissue between one pole of a bipolar energy sources contained on a first interfacing surface and a second pole of a bipolar energy source contained on a second interfacing surface. Staples and thermogenic energy are applied to the compressed tissue. In a preferred embodiment a cutting means for cutting tissue is incorporated into the instrument. <IMAGE>
Patent AU-6941301-A (AU)
Title: Internal antennas for mobile communication devices
Inventor: MAOZ JOSEPH
IPC: H01Q5/10
Filed: 2001-07-09
Abstract: An antenna resonant and radiant at a predetermined frequency band, comprising: 
a dielectric substrate having opposed faces, an electrically-conductive layer serving as a ground plane on one face of the dielectric substrate; 
an electrically conductive feed line carried on the opposite face of the dielectric substrate, said feed line having at least one feed end and at least one load end; 
and a curved slot formed in said ground plane having a feed side and a load side with respect to said feed end and load end, said slot being electromagnetically coupled to said feed line, such that said slot is resonant and radiant at said predetermined frequency band; 
characterized in that said feed line includes a change in width at least at one of said ends thereof to match the impedance of the antenna for said predetermined frequency band.
Patent AU-7410691-A (AU)
Title: Lhrh analogues
Inventor: SCHALLY ANDREW V
IPC: C07K14/575
Filed: 1991-04-05
Abstract: The present invention deals with LHRH analogs which contain cytotoxic moieties, have influence on the release of gonadotropins from the pituitary in mammals (possess high agonistic or antagonistic activity) and have antineoplastic effect. The compounds of this invention are represented by Formula I: X-R<1>-R<2>-R<3>-Ser-R<5>-R<6>(Q)-Leu-Arg-Pro-R<1><0>-NH2, wherein R<1> is pGlu or D-Nal(2), R<2> is His or D-Phe(4Cl), R<3> is Trp, D-Trp or D-Pal(3), R<5> is Tyr or Arg, R<6> is D-Lys or D-Orn, R<1><0> is Gly or D-Ala, X is hydrogen or a lower alkanoyl group of 2-5 carbon atoms, Q is a cytotoxic moiety having the formula -Q<4> or -A(Q<3>) or B(Q<1>)2 or -B(AQ<2>)2, wherein A is -NH-(CH2)n-CO- or -OC-(CH2)n-CO- where n is 2-6, B is -NH-CH2-(CH2)m-CH(NH)-(CH2)n-CO- where m is 0 or 1, n is 0 or 1, the -CO moiety of A- and of B- being bonded to an amino group on R<6>, and in the group B(AQ<2>)2, the -CO moiety of A-being bonded to an amino group on B, Q<1> is D or L-Mel, cyclopropanealkanoyl, aziridine-2-carbonyl, epoxyalkyl or 1,4-naphthoquinone-5-oxycarbonyl-ethyl, Q<2> is Q<<1>,> anthraquinonylalkoxy or doxorubicinyl, Q<3> is Q<2>, mitomicinyl, esperamycinyl or methotrexoyl, Q<4> is Q<1> or methotrexoyl and pharmaceutically acceptable salts thereof and methods of use pertaining these compounds.
Patent AU-7549496-A (AU)
Title: (S)-(+)-hydroxychloroquine
Inventor: STECHER VERA JOHANNA
IPC: A61P29/00
Filed: 1996-12-20
Abstract: The present invention provides (S)-(+)-Hydroxychloroquine substantially free of (R)-(-)-hydroxychloroquine, or a pharmaceutically acceptable acid-addition salt thereof, the use in the manufacture of a medicament for treatment of malaria, lupus erythematosus or rheumatoid arthritis and a composition containing it for the treatment of such diseases. The weight ratio of (S)-(+)-Hydroxychloroquine to (R)-(-)-hydroxychloroquine is preferably at least 90:10, most preferably at least 98:2.
Patent AU-7588491-A (AU)
Title: Iontophoretic delivery device
Inventor: LEW PATRICK J
IPC: A61N1/30
Filed: 1991-03-25
Abstract: An iontophoretic agent delivery device having donor and counter electrodes comprised of either metal or a hydrophobic polymer loaded with a conductive filler is provided. The agent reservoir in the donor electrode assembly contains about 10 to 60 wt. % hydrophobic polymer, about 10 to 60 wt. % hydrophilic polymer, and up to 50% agent. Similarly, the electrolyte reservoir contains about 10 to 60 wt. % hydrophobic polymer, about 10 to 60 wt. % hydrophilic polymer, and up to 50% electrolyte. The agent reservoir, the electrolyte reservoir and the electrodes are preferably in the form of films which are laminated to one another. The hydrophobic polymer component in the agent/electrolyte reservoir prevents the reservoir from delaminating from the metal/hydrophobic polymer based electrode, even after hydration of the reservoirs.